The Health and Human Services Department is reviewing contracts and moving to replace vaccine advisers in Robert F. Kennedy ...
Among the stocks on Morningstar’s list, the average change in fair value estimate was a 1.99% increase, above the 10-year ...
The S&P 500 has soared in recent times, delivering two consecutive years of double-digit gains, and investors -- from ...
Bexhill’s De La Warr Pavilion presents Ssh Ow, the first major solo exhibition in a UK public gallery in a decade by ...
Over the weekend the World Health Organization (WHO) announced a new setback in Uganda's Ebola Sudan outbreak. The country ...
So far 70 confirmed human cases of H5N1 infection have been reported, following a widespread outbreak across bird and cattle ...
BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a r ...
Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...
HHS review of a vaccine contract sparks worries about preparedness for a potential bird flu pandemic
HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...
U.S. involvement in WHO flu meetings, the UK's approval of Moderna's RSV vaccine, efforts against a measles outbreak in Texas ...
US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days ...
RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results